Shoukui Hu | Microbiology | Best Researcher Award

Dr. Shoukui Hu | Microbiology | Best Researcher Award

Laboratory Director at Zhengzhou Central Hospital Affiliated to Zhengzhou University, China.

Dr. Shoukui Hu is a distinguished clinical laboratory scientist with expertise in pathogenic biology and molecular biology. He currently serves as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital, Beijing, China. With more than two decades of experience in medical microbiology and molecular epidemiology, Dr. Hu has made significant contributions to infectious disease diagnostics, laboratory medicine, and hospital-based blood safety management. His academic training and career development have been rooted in prestigious national institutions such as the China Center for Disease Control and Prevention (China CDC) and Anhui Agricultural University. In addition to his administrative responsibilities, he actively leads research and training initiatives in clinical diagnostics and molecular pathogen identification. Dr. Hu has held leadership and technical roles in national and regional disease control laboratories, including serving as Deputy Director of the Microbiological Laboratory at Anhui CDC. His postdoctoral work focused on molecular epidemiology, where he deepened his knowledge of infectious disease transmission and public health responses. Dr. Hu’s ongoing commitment to improving laboratory services and his engagement in translational research have established him as a key figure in China’s hospital and public health laboratory networks. His career reflects a strong blend of leadership, innovation, and service.

📝Publication Profile

Scopus

Orcid

🎓Education

Dr. Shoukui Hu has pursued a comprehensive academic journey in microbiology, pathogenic biology, and public health. He obtained his Ph.D. in Pathogenic Biology from the National Institute for Communicable Disease Control and Prevention, China CDC, from 2009 to 2014. His doctoral studies focused on the biological mechanisms of pathogens, particularly those relevant to communicable diseases in China. Prior to his Ph.D., Dr. Hu completed his Master’s degree in Microbiology between 2001 and 2004 through a joint program between the National Institute for Communicable Disease Control and Prevention and Anhui Agricultural University. This multidisciplinary collaboration offered him both theoretical and practical exposure to microbial diagnostics and epidemiology. His academic foundation was established at Anhui Science and Technology University, where he earned his Bachelor of Science in 1999. This progression from undergraduate to doctoral studies underscores his long-standing commitment to scientific inquiry in the field of microbiology and laboratory medicine. Throughout his educational trajectory, Dr. Hu has cultivated a rigorous scientific mindset and built a strong foundation in experimental and translational research, equipping him for his later leadership roles in clinical and diagnostic laboratories.

💼Professional Experience

Dr. Shoukui Hu brings over 20 years of professional experience in clinical diagnostics, public health, and laboratory management. Since November 2016, he has served as the Senior Technologist and Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital. In this role, he oversees diagnostic workflows, laboratory quality control, and blood safety protocols, while also mentoring technical staff. From July 2014 to October 2016, he undertook a postdoctoral fellowship in Molecular Epidemiology at the National Institute for Communicable Disease Control and Prevention, China CDC, contributing to research on infectious disease patterns and pathogen evolution. Briefly in 2014, he worked as an Associate Senior Technologist in the Clinical Laboratory at Peking University International Hospital, where he implemented advanced diagnostic technologies. Prior to these roles, Dr. Hu held a key leadership position from 2004 to 2014 as Deputy Director of the Microbiological Laboratory at Anhui CDC. There, he played a critical role in regional disease surveillance, outbreak investigation, and microbiological diagnostics. His rich professional background encompasses both hospital-based and public health laboratory environments, making him a versatile and experienced leader in the Chinese medical laboratory system.

🔬Research Interest

Dr. Shoukui Hu’s primary research interests lie in pathogenic biology and molecular biology, particularly focusing on the mechanisms of infectious disease transmission, diagnosis, and control. He is particularly interested in molecular diagnostics for communicable diseases, including the development and optimization of real-time PCR, nucleic acid amplification, and sequencing-based identification techniques. His work explores the molecular epidemiology of bacterial and viral pathogens, aiming to trace their origins, genetic evolution, and resistance profiles. These interests were further honed during his postdoctoral fellowship, where he investigated the molecular characteristics and transmission dynamics of key human pathogens. Additionally, Dr. Hu is actively engaged in research related to clinical laboratory improvement, blood transfusion safety, and the integration of novel biomolecular tools into diagnostic workflows. He collaborates with multidisciplinary teams to enhance infectious disease surveillance and outbreak response capacity in clinical and public health settings. Through his dual expertise in molecular biology and clinical diagnostics, Dr. Hu seeks to bridge the gap between research and practice, with the goal of improving patient care and public health outcomes through science-driven innovations.

🧠Research Skills

Dr. Shoukui Hu possesses a diverse set of research and laboratory skills that support his work in clinical diagnostics and molecular epidemiology. He is proficient in a wide range of molecular biology techniques, including DNA/RNA extraction, PCR, real-time PCR, gene sequencing, and electrophoresis. His expertise also extends to microbial culture, antimicrobial susceptibility testing, and biosafety procedures essential in infectious disease laboratories. Dr. Hu is well-versed in laboratory quality control systems, having implemented and supervised ISO-compliant workflows in clinical and CDC laboratories. His analytical skills include data interpretation in molecular epidemiological studies, as well as the use of bioinformatics tools for pathogen genotyping and phylogenetic analysis. Additionally, Dr. Hu has experience in managing laboratory operations, training personnel, and conducting clinical validations of diagnostic assays. He has led or contributed to several research projects investigating the molecular characteristics of emerging pathogens, particularly in the context of hospital-acquired infections and public health emergencies. His integrated technical, managerial, and research capabilities make him a valuable asset in both academic and clinical laboratory environments, contributing to innovation in infectious disease control and laboratory diagnostics.

🏆Awards and Honors

While specific awards and honors have not been listed in the original profile, Dr. Shoukui Hu’s career progression and leadership roles strongly reflect recognition of his expertise and contributions within the Chinese clinical and public health sectors. Achieving the position of Director of the Clinical Laboratory and Blood Transfusion Department at a major teaching hospital such as Peking University Shougang Hospital is a testament to his excellence and leadership. His selection for a competitive postdoctoral fellowship in molecular epidemiology at China CDC indicates strong endorsement by national-level scientific authorities. Moreover, his advancement to senior technologist and associate senior technologist roles across various institutions signifies sustained professional recognition. It is likely that Dr. Hu has received internal commendations for laboratory management, infectious disease response, and quality assurance contributions, though these are not documented here. His scientific credibility and technical expertise also position him as a key collaborator in research and diagnostic innovation. As his work continues to gain visibility in both academic and clinical contexts, further formal recognitions and awards may follow.

📈Author Metrics

As of the latest available data, Dr. Shoukui Hu has made significant scholarly contributions in the fields of pathogenic biology and molecular diagnostics. His author metrics are as follows:

  • Total Citations: 515

  • Citing Documents: 442

  • Total Publications: 35

  • h-index: 14

These metrics reflect Dr. Hu’s impact and influence in the scientific community, particularly in microbiology, molecular epidemiology, and clinical diagnostics. An h-index of 14 indicates that at least 14 of his publications have each received 14 or more citations, underscoring both the relevance and consistency of his research output. His work continues to be cited by a wide array of researchers and clinicians, demonstrating ongoing engagement with and recognition of his scholarly contributions.

📌Publications Top Notes

1. Isolation of Fluconazole-Resistant South Asian Clade Candida auris in Beijing, China

  • Journal: American Journal of Tropical Medicine and Hygiene

  • Year: April 2025

2. Influence of Helicobacter pylori on Composition and Function of Gastric Microbiota in Patients with Chronic Non-Atrophic Gastritis

  • Journal: Heliyon

  • Year: May 2024

3. The Role of Toll-Like Receptors in Immune Tolerance Induced by Helicobacter pylori Infection

  • Journal: Helicobacter

  • Year: August 2023

4. Comparative Analysis of the Gut Microbiota of Wild Adult Rats from Nine District Areas in Hainan, China

  • Journal: World Journal of Gastroenterology

  • Year: June 2023

5. Ultra-Efficient Multiple Cross Displacement Amplification–Lateral Flow Biosensor (MCDA–LFB) for Serogroup Identification of Prevalent Neisseria meningitidis

  • Journal: Analytical Biochemistry

  • Year: May 2022

🧾Conclusion

Dr. Shoukui Hu stands out as a dedicated leader and researcher in the fields of pathogenic biology and molecular diagnostics. His career spans prestigious institutions, from regional CDC laboratories to leading university-affiliated hospitals, reflecting a blend of public health service and clinical excellence. With a strong foundation in microbiology and molecular biology, he has made impactful contributions to infectious disease diagnosis and laboratory safety. Dr. Hu’s work enhances the reliability of diagnostic laboratories and advances scientific understanding of pathogen behavior and transmission. His leadership at Peking University Shougang Hospital has played a pivotal role in modernizing laboratory services and implementing high-quality blood transfusion practices. By merging his academic insights with practical experience, he continues to foster innovation in diagnostic science and contribute meaningfully to China’s public health infrastructure. Dr. Hu exemplifies the critical role of clinical laboratory professionals in shaping modern medicine, and his ongoing commitment to research, education, and clinical service marks him as a key contributor to the future of diagnostic healthcare and infectious disease control in China.

 

Ningning Song | Microbiology | Best Researcher Award

Prof. Dr. Ningning Song | Microbiology | Best Researcher Award

Ningning Song at Shandong Second Medical University, China.

Dr. Ningning Song is a distinguished microbiologist specializing in bacterial transcriptional regulation and tuberculosis pathogenesis. She has made significant contributions to identifying regulatory proteins involved in the latent and dormant infection stages of M. tuberculosis. Her research on small molecules affecting transcriptional regulation has provided valuable insights into tuberculosis treatment and drug development. Dr. Song has been instrumental in fostering interdisciplinary collaborations, securing patents, and leading pioneering studies in molecular diagnostics.

Publication Profile

Scopus

Educational Details

Dr. Ningning Song holds a Ph.D. in Molecular Biology, specializing in UVB research, from Belgium. Her academic expertise lies in microbiology, with a strong emphasis on transcriptional regulation, bacterial pathogenesis, and molecular diagnostics.

Professional Experience

Dr. Song is a Professor and the leader of the Young Talent Education Innovation Team of Shandong Province. She serves as a Special Expert under the Weifang Yuandu Scholars program and is the Director of the Weifang Key Laboratory of Respiratory Pathogens and Drug Therapy. Over her career, she has successfully led four National Natural Science Foundation projects, published more than 40 research articles, secured six authorized patents, and contributed to two major talent development projects. As an editorial board member for Frontiers in Cellular and Infection Microbiology, she plays a key role in advancing research in her field.

Research Interest

Dr. Song’s research focuses on the transcriptional regulation of Mycobacterium tuberculosis, omics-based screening of virulence factors, and molecular diagnosis of tuberculosis. Her work extends to exploring nanomaterial-based drug delivery systems for drug-resistant bacteria in collaboration with Tianjin University and investigating regulatory mechanisms of M. tuberculosis with the Chinese Academy of Agricultural Sciences.

Author Metrics & Achievements

    • Total Research Publications: 42 (SCI, Scopus)

    • Completed/Ongoing Research Projects: 9

    • Patents Published/Under Process: 9

    • Books Published (ISBN): 2

    • Editorial Appointments: Frontiers in Cellular and Infection Microbiology

    • Collaborations: Co-published five articles with Tianjin University and the Chinese Academy of Agricultural Sciences

    • Professional Memberships: Chinese Association for the Defense of Tuberculosis

Top Noted Publication

  • Engineered Nanovesicles for the Precise and Noninvasive Treatment of Deep Osteomyelitis Caused by MRSA Infection with Enhanced Immune Response
    Authors: Xingyue Yang, Ren Fang, Xiaotian Li, Yumiao Zhang, Ningning Song
    Journal: ACS Applied Materials & Interfaces, 2025
    Summary: This study introduces engineered nanovesicles designed for the targeted and noninvasive treatment of deep osteomyelitis caused by MRSA infections. The nanovesicles enhance the immune response, offering a promising therapeutic strategy for challenging bone infections.

  • Novel Target and Cofactor Repertoire for the Transcriptional Regulator JTY_0672 from Mycobacterium bovis BCG
    Authors: Hui Wang, Xiaotian Li, Shuxian Wang, Zhaoli Li, Ningning Song
    Journal: Frontiers in Microbiology, 2024
    Summary: This research identifies new targets and cofactors associated with the transcriptional regulator JTY_0672 in Mycobacterium bovis BCG. The findings provide insights into the bacterial transcriptional regulation mechanisms, contributing to the understanding of mycobacterial gene expression.

Conclusion

Dr. Ningning Song is a highly accomplished microbiologist whose contributions to bacterial transcriptional regulation, tuberculosis pathogenesis, and nanomaterial-based drug delivery make her a strong candidate for the Best Researcher Award. Her strong publication record, leadership roles, patents, and interdisciplinary collaborations position her as a leading researcher in her field. Addressing citation impact, global collaborations, and industry applications could further solidify her standing among top researchers worldwide.